Cellectis Inc. (CLLS) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero and a member of our team will be happy to help you. ¶¶ ¶¶ . . . . ¶¶ ¶. Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero, and a member of our team will be happy to help you. ¶¶ Thank you. ¶¶ And a member of our team will be happy to help you. ¦ ¦ ¦ ¶¶ ¶¶ please stand by your meeting is about to begin Hello and welcome everyone to today's Selectus Full Year 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. To register to ask a question at any time, please press star 1 on your telephone keypad. Please note this call is being recorded and that we are standing by if you should need any assistance. It is now my pleasure to turn the meeting over to Arthur Strill, Chief Financial Officer and Chief Business Officer. Please go ahead. Good morning and welcome everyone to Selectus' fourth quarter and full year 2025 business update and financial results conference call. Joining me on the call today are Dr. André Choulika, our Chief Executive Officer, and Dr. Adrian Kilcoyne, our chief medical officer. Yesterday evening, Selectus issued a 20th and press release reporting our financial statements for the 12-month period ended December 31st, 2025, and a business update. The report and press release are available on our website at selectus.com. As a reminder, we'll make statements regarding Selectus financial outlook, including the sufficiency of cash-to-fund operations, in addition to its manufacturing, regulatory, and product development sta...